Powder: -20°C for 3 years | In solvent: -80°C for 1 year
LY3154207 is a subtype selective, potent, and orally available human dopamine D1 receptor positive allosteric modulator (PAM) with minimal allosteric agonist activity (EC50=3 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 10-14 weeks | $ 432.00 | |
25 mg | 10-14 weeks | $ 1,430.00 | |
50 mg | 10-14 weeks | $ 1,860.00 | |
100 mg | 10-14 weeks | $ 2,690.00 |
Description | LY3154207 is a subtype selective, potent, and orally available human dopamine D1 receptor positive allosteric modulator (PAM) with minimal allosteric agonist activity (EC50=3 nM). |
Targets&IC50 | D1 receptor (human):(EC50)3 nM |
In vitro | In a study conducted on HEK293 cells transiently expressing D1 receptors from human, dog, rhesus monkey, and mouse, LY3154207 demonstrated EC50 values of 2.3 nM, 2.0 nM, 2.5 nM, and 62.1 nM, respectively[1]. |
Molecular Weight | 450.4 |
Formula | C24H29Cl2NO3 |
CAS No. | 1638667-79-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
LY3154207 1638667-79-4 Others LY 3154207 LY-3154207 inhibitor inhibit